Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glutamine for the Prevention of Radiation Toxicity in Subjects Undergoing Breast Conserving Therapy

NCT02012608 is registered in ClinicalTrials.gov with University of Arkansas as lead sponsor.

NCT NCT02012608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02012608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glutamine for the Prevention of Radiation Toxicity in Subjects Undergoing Breast Conserving Therapy
Lead sponsor
University of Arkansas
Phase
Phase 2
Overall status
Terminated
Start date
June 30, 2014
Completion date
April 30, 2019
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer